市場調查報告書
商品編碼
1390644
肉毒桿菌毒素市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Botulinum Toxin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球肉毒桿菌毒素市場規模達54億美元。展望未來, IMARC Group預計到2028年市場規模將達到84億美元,2022-2028年複合年成長率(CAGR)為7.64%。
肉毒桿菌毒素是肉毒桿菌產生的神經毒素,肉毒桿菌是一種厭氧、革蘭氏陽性、產芽孢桿,常見於植物、土壤、水和動物腸道。它在各種醫療狀況的管理中發揮著重要作用。這些病症包括斜視和局部肌張力失調、顏面肌痙攣、頭痛、唾液分泌過多、多汗症和痙攣性運動障礙。此外,它也用於治療對現有藥物治療有部分反應的各種慢性疾病。如今,它也用於暫時減少皺眉紋、皺紋以及臉部、下巴、頸部和胸部皺紋的美容目的。
慢性和急性疾病的盛行率和診斷率顯著上升是推動市場成長的關鍵因素之一。肉毒桿菌毒素廣泛應用於治療皮膚病,例如平滑肌過度活躍、腺體活動異常和多汗症。此外,個人美容意識的不斷增強,以及他們接受重建和整容手術的意願,正在促進市場的成長。此外,美容旅遊的興起,加上社交媒體影響力的不斷增強、城市化的快速發展以及人均收入的不斷膨脹,正在對市場產生積極的影響。除此之外,隨著年齡的成長,皮膚變得更容易出現皺紋和下垂,不斷成長的老年人口以及保持年輕健康皮膚的願望正在推動市場成長。此外,透過組合不同血清型來開發新的強效毒素可以減少總單位和總抗原劑量,並提高有效性和作用持續時間。這些進步預計將為市場創造積極的前景。
The global botulinum toxin market size reached US$ 5.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.64% during 2022-2028.
Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum, which is an anaerobic, gram-positive, spore-forming rod commonly found in plants, soil, water, and intestinal tracts of animals. It plays a significant role in the management of a wide variety of medical conditions. These conditions include strabismus and focal dystonia, hemifacial spasm, headaches, hypersalivation, hyperhidrosis, and spastic movement disorders. Moreover, it is utilized in the treatment of various chronic diseases that respond partially to available medical treatments. Nowadays, it is also used for the cosmetic purpose of temporarily reducing frown lines, creases, and wrinkles on the face, chin, neck, and chest.
A significant rise in the prevalence and diagnosis of chronic and acute diseases represents one of the key factors bolstering the market growth. Botulinum toxin finds extensive applications in the treatment of dermatological conditions, such as overactive smooth muscles, abnormal activity of glands, and hyperhidrosis. Moreover, the rising beauty consciousness among individuals, along with their willingness to undergo reconstructive and cosmetic surgeries, is contributing to market growth. In addition, the emerging trend of cosmetic tourism, in confluence with the increasing influence of social media, rapid urbanization, and inflating per capita income, is influencing the market positively. Apart from this, as the skin becomes more susceptible to wrinkles and sagging with age, the growing geriatric population and the desire to retain young and healthy skin are bolstering the market growth. Furthermore, the development of new potent toxins by combining different serotypes can reduce the total units and overall antigenic dose and improve effectiveness and duration of effect. These advancements are projected to create a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global botulinum toxin market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.
Toxin Type A
Toxin Type B
Therapeutics
Aesthetics
Hospitals and Clinics
Dermatology Clinics
Spas and Cosmetic Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Eisai Co. Ltd, Evolus Inc, Galderma SA, HUGEL Inc., Ipsen Group, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Metabiologics Inc. and Revance Therapeutics Inc.